abstract |
The present invention relates to a compound corresponding to one of formulas I to XXI; a pharmaceutical composition comprising at least one such compound; and the use of at least one such compound for the preparation of a medicament for treating, in a subject, a genetic disease resulting from at least one disease resulting from at least one splicing abnormality. |